lysosomal 铁的激活会在癌症中触发铁化
Raphaël Rodriguez1, Tatiana Cañeque2, Leeroy Baron2
1Institut Curie, CNRS.
Research square
|April 25, 2024
概括
溶酶体中的铁驱动铁,一种细胞死亡形式. 一种新的化合物fentomycin,向 lysosomes 激活铁,促进癌细胞死亡和减少瘤生长.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 铁催化脂质氧化,诱导铁亡,这是一个受调节的细胞死亡途径.
- 了解铁介导脂质氧化的细胞位置对于开发化向疗法至关重要.
- 小分子为细胞化学提供精确的时空控制.
研究的目的:
- 为了研究 lysosomal 铁在铁亡中的作用.
- 设计和评估一种用于向诱导铁死的新型双功能化合物.
- 探索向癌症中的溶酶体铁的治疗潜力.
主要方法:
- 利用铁灭抑制剂liproxstatin-1 (Lip-1) 来探测铁在溶酶体中的作用.
- 设计和合成了芬托米辛,一种化向的仿真体 (LIPTAC).
- 在小鼠乳腺癌转移模型中评估了芬托米辛杀死癌细胞 (肉瘤,胰腺管腺癌) 的疗效及其体内作用.
主要成果:
- 证明liproxstatin-1在溶酶体内禁用铁,提供保护.
- 芬托米辛向血膜的脂,并在内细胞突变时激活 lysosomal 铁,诱导铁.
- 芬托米辛有效地消除了原发性肉瘤和胰腺管道腺癌细胞,特别是CD44高的亚种群.
- 芬托米辛在体内减少了瘤生长,并在乳腺癌转移模型中耗尽了CD44高细胞.
结论:
- 溶解体铁是铁亡的一个关键触发因素.
- 溶解体铁氧化还原化学可以在治疗上被利用来诱导铁.
- 芬托米辛代表了一种有前途的LIPTAC药物,用于向转移性和耐药性癌症的铁驱动性铁.
相关概念视频
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
The Early Endosome: Endocytosis of Transferrin
3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K


